Search

everythinglearnresearchcommunity

for

Search:↓

New understanding and treatments for hair loss are improving, but more research is needed.

A high-fat diet caused severe health problems in female macaques but was reversible with a normal diet, while male macaques reacted differently.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

A cat's hair loss was linked to a severe pancreatic cancer.

SIM01 significantly reduced post-COVID symptoms and is safe.

A dog's skin calcification condition resolved without treatment after a bacterial infection.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Long COVID patients may have hormonal imbalances linked to their symptoms.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

People with early-onset hair loss have higher risk of heart issues, so early screening is important.

A quick and simple method was created to identify minoxidil in hair-growth products using micellar electrokinetic capillary chromatography.

The conclusion is that measuring how drugs partition into artificial sebum is important for predicting their delivery into hair and sebaceous follicles, and it provides better information than traditional methods.

Low-dose oral minoxidil can be effective for hair loss but should be avoided in people with certain heart conditions and severe liver problems.